Assessing the Evidence for Health Care Decision Makers
Assessing the Evidence for Health Care Decision Makers are public online, interactive questionnaires to evaluate modeling, observational, and network meta-analysis/indirect treatment comparison studies. These questionnaires provide greater uniformity and transparency in the evaluation and use of evidence for coverage and health care decision making with the ultimate goal of improving patient outcomes.
ISPOR Global Health Care Systems Road Map
The ISPOR Global Health Care Systems Road Map provides information on country/region-specific decision-making processes for regulatory (market access) approval, reimbursement and economic evaluations of pharmaceuticals and medical devices and diagnostics.
Pharmacoeconomic Guidelines Around The World
Pharmacoeconomic evaluation is an analytical tool used with increasing frequency to assist decision making in the financing and management of pharmaceutical products in the health care system or national health insurance programs of an individual country. Pharmacoeconomic (PE) guidelines can be used as a standard for preparation of studies to be included in application for reimbursement, a guide for designing and conducting a study, or a template for evaluating the economic study reports.
ISPOR Health Technology Assessment Roundtables
The purpose of the ISPOR HTA Roundtables is to provide a forum to discuss, debate, and share, health technology issues, to bridge the gap between HTA agencies, health care decision-makers and outcomes researchers to optimize healthcare decisions using outcomes research.
Directory of Health Technology Assessment Organizations Worldwide
An ever-expanding directory of HTA-related organizations from around the world.